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Abstract
Background: High prevalence of obesity and cardiovascular disease is attributable to sedentary lifestyle and eating
diets high in fat and refined carbohydrate while eating diets low in fruit and vegetables. Epidemiological studies
have confirmed a strong association between eating diets rich in fruits and vegetables and cardiovascular health.
The aim of this pilot study was to determine whether drinking fresh carrot juice influences antioxidant status and
cardiovascular risk markers in subjects not modifying their eating habits.
Methods: An experiment was conducted to evaluate the effects of consuming 16 fl oz of daily freshly squeezed
carrot juice for three months on cardiovascular risk markers, C-reactive protein, insulin, leptin, interleukin-1a, body
fat percentage, body mass index (BMI), blood pressure, antioxidant status, and malondialdehyde production.
Fasting blood samples were collected pre-test and 90 days afterward to conclude the study.
Results: Drinking carrot juice did not affect (P > 0.1) the plasma cholesterol, triglycerides, Apo A, Apo B, LDL, HDL,
body fat percentage, insulin, leptin, interleukin-1a, or C-reactive protein. Drinking carrot juice decreased (P = 0.06)
systolic pressure, but did not influence diastolic pressure. Drinking carrot juice significantly (P < 0.05) increased the
plasma total antioxidant capacity and decreased (P < 0.05) the plasma malondialdehyde production.
Conclusion: Drinking carrot juice may protect the cardiovascular system by increasing total antioxidant status and
by decreasing lipid peroxidation independent of any of the cardiovascular risk markers measured in the study.
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Background
Despite a gradual decline in mortality from cardiovascu-
lar disease (CVD), it is still the leading cause of both
morbidity and mortality in the United States [1].
Approximately 864,000 Americans die each year from
CVD and this figure makes up 35% of the total deaths
in the United States [2]. In recent years, there have been
disturbing increases in the prevalence of CVD risk fac-
tors like diabetes, obesity, and the metabolic syndrome
which collectively may negate the downward trends in
CVD mortality [1,3,4].
Obesity elevates the risk of developing metabolic syn-
drome, diabetes, and CVD [5-7]. Obesity is thought to
initiate a cascade of events leading to systemic
inflammation and increases in circulating C-reactive
protein, insulin resistance, and dyslipidemia [7]. In 1998,
the American Heart Association considered obesity to
be one of the major risk factors for coronary heart dis-
ease [8]. Other risk factors for CVD include a higher
body mass index (BMI), the marker commonly used to
establish obesity, which has been shown to be indepen-
dently associated with hypertension, elevated total cho-
lesterol and low-density lipoprotein (LDL) cholesterol
levels, and lower high density lipoprotein (HDL) choles-
terol [9-12]. The optimal BMI for adults 18 to 85 years
of age is from 23 to 25 for most races [13]. Evidence
has demonstrated that people with elevated BMI are at
higher risk of developing CVD compared with those of
normal BMI [14,15]. Additionally, the presence of meta-
bolic syndrome is predicted to shorten life leading to
death at younger ages [16].
Diets high in fat and cholesterol are the major factors
contributing to CVD. Dietary modification and lifestyle
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changes are suggested to be effective strategies to pre-
vent CVD [17]. The National Heart, Lung, and Blood
Institute (NHLBI) recommend the Therapeutic Lifestyle
Change (TLC) diet to improve heart health in indivi-
duals at risk for CVD. The TLC diet consists of redu-
cing intake of saturated and total fat from animal
products and increasing the intake of fibrous vegetables,
fruits, whole grains, and legumes [18]. Increased fruit
and vegetable consumption has been found to play a
key role in preventing heart disease. In a follow up of
the Nurse’s Health Study, an additional serving per day
of fruits and vegetables was associated with a 4% reduc-
tion in the risk of coronary heart disease [19]. Fruits
and vegetables contain many nutrients which may be
associated with reduced risk for heart disease, including
fiber, vitamins, minerals, and phytochemicals. Phyto-
chemicals found in fruits and vegetables have been
shown to reduce inflammation, oxidative stress, and
other markers of CVD [20].
Among common fruits and vegetables, carrots are
high in fibers, carotenoids, vitamins C and E, and phe-
nolics such as p-coumaric, chlorogenic, and caffeic acids
[21]. Consuming foods containing phenolic compounds
has decreased the risk of vascular diseases in previous
studies [22,23]. Phenolic compounds are dietary antioxi-
dants found in plants that are shown to inhibit LDL oxi-
dation, inhibit platelet aggregation and adhesion,
decrease total and LDL cholesterol, and induce endothe-
lium-dependent vaso-relaxation [24-26]. Oral intake of
carrot juice also displays other beneficial physiological
effects including reduced oxidative DNA damage [27],
increased levels of plasma antioxidants [28], and reduced
inflammation [29]. In the Lipid Research Clinics Coron-
ary Primary Prevention Trial (LRC-CPPT), men were
tracked over 13 years and results revealed that those
with the highest plasma carotenoid levels had lower risk
of coronary heart disease [30]. In a 12-year follow-up of
the Prospective Basel Study, Eicholzer and colleagues
found that the risk of ischemic heart disease is increased
by 1.53 Relative Risk in those with the lowest plasma
carotene concentrations [31]. Inflammation has been
shown to be a strong predictor of CVD and serum b-
carotene inversely correlates with C-reactive protein and
interleukin-6 [29,32].
Previous studies have shown beneficial effects of eat-
ing high fiber diets on lowering cardiovascular risk fac-
tors [33-35]. One other study has shown potential
benefit of fruit and vegetable juice concentrate on cardi-
ovascular prevention [36]. The goal of present study was
to evaluate the potential role of drinking 16 ounces
fresh squeezed carrot juice (equivalent to one pound of
fresh carrot) daily on lowering cardiovascular risk mar-
kers in adults with elevated cholesterol and triglycerides.
Methods
Subjects
In this study, eight males and nine females from Texas
A & M University-Kingsville (TAMUK) faculty and staff
(n = 17) with elevated plasma cholesterol and triglycer-
ide levels were the study participants. Each subject was
asked to drink 16 fl oz fresh carrot juices daily for the
three month duration of the study. The research study
was approved by TAMUK IRB-board prior to initiation
of the study. Participants agreed to drink the carrot
juice daily and signed a consent form to agree to rules
and regulations of the study. Carrots were juiced and
delivered to research participants daily. Weight and
height were measured both pre-test and post-test to cal-
culate BMI status. Fasting blood samples were collected
by a licensed nurse at the start of the study and after 90
days when the study was concluded. The blood samples
were collected in tubes and centrifuged at 1,500x g for
15 min. The blood chemistry and lipid panels were ana-
lyzed using Modular Analytics D 2400 system and
Cobas Integra 800 of Roche Diagnostics Corp. Indiana-
polis, IN.
Outcome Measures
Blood Pressure Collection
Three random blood pressures from the right upper arm
were taken using the OMRON Model #HEM 711. Blood
pressure was measured at the beginning and end of the
study. The blood pressure was taken from each subject
and repeated if: 1) an error occurred in the reading, 2)
the subjects seemed anxious or nervous, or 3) the blood
pressure measurement was above the normal range (120
mm Hg/80 mm Hg).
Bioelectrical Impedance Analysis
The Bioelectrical Impedance Analysis (BIA) technique
was used to estimate percentage of body fat using
Quantum II (RJL Systems, 2006, Clinton Twp., MI). The
BIA test was performed while each subject was lying
supine with their arms and legs spread open. After the
electrode site was cleaned with isopropyl alcohol, elec-
trode patches with self-adhesive conducting gel were
attached to the dorsal surface of the right foot and right
hand. The electrodes introduced an alternating current
(50 kHz) at the base of the toes and fingers and the
Quantum II measures the voltage changes (RLJ Systems,
2006, Clinton Twp., MI). The BIA was measured at the
beginning and end of the study.
Inflammatory Markers and Hormones
The plasma interleukin-1a was determined as a pro-
inflammatory marker (R&D System, Minneapolis, MN).
The plasma C-reactive protein was analyzed using a rat
C-reactive protein ELISA kit as an index for inflamma-
tion (Life Diagnostics, Westchester, PA, USA). Insulin
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was analyzed to determine an insulin resistant state
(Linco Research, Inc. St. Charles, MI). Leptin was ana-
lyzed as an adiposity hormone (Linco Research, Inc. St.
Charles, MI).
Total Antioxidant Status and Malondialdehyde Production
The plasma was collected and an aliquot was refriger-
ated for total antioxidant status using a commercially
available kit (Calbiochem, San Diego, CA, USA) as a
quantitative measure of circulating antioxidant status.
The plasma malondialdehyde was evaluated as an indi-
cator of lipid peroxidation using a kit from Northwest
life science (Vancouver, WA, USA).
Analysis
The experimental design was a pre-test/post-test and a
comparison student t-test was performed to determine
the effects of drinking 16 fl oz fresh carrot juice daily as
an independent variable on variables of interest at base-
line and 90 days after the completion of the study as
outlined by Steel and Torrie [37].
Results
Drinking 16 fl oz of carrot juice daily for three months
did not (P > 0.1) alter subject’s weight, body fat percen-
tage, or BMI (Table 1). While drinking carrot juice
numerically lowered systolic pressure (P = 0.06) while
diastolic pressure was unchanged (Table 1). The fasting
plasma chemistry including glucose, triglycerides, cho-
lesterol, HDL, LDL, VLDL, the hormones insulin and
leptin, and the inflammatory markers interleukin-1a and
C-reactive protein were unaffected from consuming car-
rot juice (Table 1). Plasma Apo A and Apo B were not
(P > 0.1) significantly affected by drinking carrot juice
(Table 1). However, the plasma antioxidant status was
significantly (P < 0.05) increased while the plasma mal-
ondialdehyde production was significantly (P < 0.05)
decreased after drinking carrot juice (Table 1).
Comparing the males to the females, men weighed
more and were taller than the female subjects (Table 2).
The plasma chemistry, lipid panel, blood pressure, and
plasma antioxidant capacity were not (P > 0.1) different
between men and women participants (Tables 2 and 3).
However, the plasma interleukin-1a, Apo B, and malon-
dialdehyde were significantly (P < 0.05) higher in men
(Table 3), while the percentage of body fat, insulin, and
leptin were higher (P < 0.05) in women (Tables 2 and
3). It is interesting to note that at baseline, the men had
significantly higher (P < 0.05) plasma malondialdhyde
concentration than the women, but after drinking carrot
juice for 90 days, the plasma malondialdhyde concentra-
tion was significantly reduced (P < 0.05) and there was
no difference in the plasma malondialdehyde concentra-
tion between men and women participants at the end of
the study.
Discussion
In the present study, the lack of effects of carrot juice
on cardiovascular markers may well be attributed to the
fact that no change in eating pattern was requested [38].
The subjects were told to continue with their daily life-
style and drink one glass containing 16 fl oz (480 mL)
of carrot juice as a morning snack.
Despite no change in anthropometric or lipid panels,
carrot juice contributed to a 5% reduction in systolic
blood pressure. The trend in systolic blood pressure
lowering effect of carrot juice is consistent with the
National Heart, Lung, and Blood Institute’s recommen-
dations to increase intake of vegetables as part of a diet-
ary pattern [39]. It is also consistent with the finding
that systolic blood pressure, rather than diastolic, is
Table 1 Effects of drinking carrot juice on
anthropometrics, blood Pressure, blood chemistry, lipid
panel, hormones, inflammatory markers, and antioxidant
status
Variables Pre-Test Post-Test
Anthropometric
Body weight (Kg) 83 ± 16 83 ± 16
Height (cm) 165 ± 2 165 ± 2
BMI 30 ± 2 30 ± 2
Fat % 28 ± 2 33 ± 2
Blood Pressure
Systolic (mm Hg) 126.5 ± 2 120.5 ± 2
Diastolic (mm Hg) 77 ± 2 75 ± 2
Blood Chemistry
Na (mmol/L) 140 ± 0.4 139 ± 0.4
K (mmol/L) 4.16 ± 0.07 4.32 ± 0.07
Ca (mg/dl) 9.4 ± 0.07 9.5 ± 0.07
Albumin (g/dL) 4.26 ± 0.06 4.30 ± 0.06
Glucose (mg/dL) 94 ± 1.9 93 ± 1.9
Lipid panel
TAG (mg/dL) 115 ± 14 123 ± 14
Cholesterol (mg/dL) 212 ± 8 218 ± 8
HDL (mg/dL) 55 ± 5 54 ± 5
VLDL 30 ± 4 32 ± 4
LDL (mg/dL) 128 ± 7 133 ± 7
Apo A (mg/dL) 162 ± 9 153 ± 9
Apo B (mg/dL) 102 ± 5 103 ± 5
Hormones
Insulin (μU/mL) 10 ± 1.1 9 ± 1.1
Leptin (ng/mL) 22 ± 2.8 21 ± 2.8
Inflammatory markers
Interleukin-1a (pg/mL) 1.48 ± 0.13 1.82 ± 0.15
C-reactive protein (mg/L) 3.74 ± 0.43 2.75 ± 0.45
Antioxidant status
Total antioxidant capacity (mM) 0.81 ± 0.04b 1.03 ± 0.04a
Malondialdehyde (μM) 42 ± 6a 18 ± 6b
a,bMeans with unlike superscript are significantly (P ≤ 0.05) different from each
other.
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more sensitive to nutrient intake modifications [40]. The
nutrients present in carrot juice, including fiber, potas-
sium, nitrates, and vitamin C could have contributed to
the effect seen in lowering systolic blood pressure [41].
Elevated blood pressure is a primary risk factor for the
development of CVD and is described as a component
of the metabolic syndrome [42]. Carrots are a rich
source of nitrates, which may be converted into nitric
oxide to increase vasodilation, possibly decreasing blood
pressure. The Mediterranean diet, known for relatively
low rates of CVD compared to the typical Western diet,
is rich in dietary nitrates and green leafy vegetables
containing potassium [43]. Carrot juice is also a rich
source of potassium which may in part have contributed
to lowering systolic blood pressure [44].
The lack of effect from drinking carrot juice on the
plasma inflammatory markers as well as insulin and lep-
tin may have been because insulin, leptin, interleukin-
1a, and C-reactive protein were all within normal
ranges. Our report is inconsistent with an earlier finding
suggesting that elevated C-reactive protein was indepen-
dently associated with higher BMI and higher triglycer-
ides [45]. However, our results are consistent with those
who reported that the mean values of cholesterol,
Table 2 Gender differences on anthropometrics, blood
Pressure, blood chemistry, and insulin
Variables Female Male
Body weight (Kg)
Pre 75 ± 8b 90 ± 8a
Post 76 ± 5b 90 ± 8a
Height (cm)
Pre 155 ± 1b 173 ± 1a
Post 157 ± 1b 173 ± 1a
BMI
Pre 31 ± 2 30 ± 2
Post 30 ± 2 30 ± 2
Fat (%)
Pre 41 ± 2a 18 ± 2b
Post 43 ± 3a 20 ± 3b
Systolic pressure (mm Hg)
Pre 125 ± 3 127 ± 3
Post 118 ± 2 122 ± 2
Diastolic pressure (mm Hg)
Pre 78 ± 2 75 ± 2
Post 75 ± 2 74 ± 2
Na (mmol/L)
Pre 139 ± 0.6 140 ± 0.6
Post 128 ± 0.6 139 ± 0.6
K (mmol/l)
Pre 4.14 ± 0.09 4.30 ± 0.11
Post 4.15 ± 0.09 4.40 ± 0.11
Ca (mg/dL)
Pre 9.46 ±0.11 9.59 ± 0.11
Post 9.44 ± 0.07 9.32 ± 0.07
Albumin (g/dL)
Pre 4.2 ± 0.08 4.3 ± 0.09
Post 4.2 ± 0.08 4.6 ± 0.09
Glucose (mg/dL)
Pre 92 ± 3 96 ± 3
Post 93 ± 3 93 ± 3
Insulin (μU/mL)
Pre 11.80 ± 1.25a 9.00 ± 1.30b
Post 11.72 ± 1.25a 7.80 ± 1.35b
a,bMeans with unlike superscript are significantly (P ≤ 0.05) different from each
other.
Table 3 Gender differences on lipid panel, leptin,
inflammatory markers, and antioxidant status
Variables Female Male
Triglyceride (mg/dL)
Pre 111 ± 18 117 ± 8
Post 119 ± 21 131 ± 23
Cholesterol (mg/dL)
Pre 210 ± 11 213 ± 12
Post 209 ± 11 228 ± 12
HDL (mg/dL)
Pre 60 ± 7 48 ± 8
Post 58 ± 7 48 ± 8
VLDL (mg/dL)
Pre 27 ± 5 31 ± 5
Post 25 ± 5 38 ± 5
LDL (mg/dL)
Pre 123 ± 10 132 ± 11
Post 125 ± 11 141 ± 11
Apo A (mg/dL)
Pre 169 ± 12 154 ± 12
Post 154 ± 13 151 ± 13
Apo B (mg/dL)
Pre 93 ± 6b 111 ± 7a
Post 91 ± 6b 115 ± 7a
Leptin (ng/mL)
Pre 35 ± 3a 8 ± 3b
Post 32 ± 3a 10 ± 4b
Interleukin-1a (pg/mL)
Pre 1.30 ± 0.18c 1.83 ± 0.09ab
Post 1.43 ± 0.18bc 2.00 ± 0.09a
C-reactive protein (mg/dL)
Pre 4.16 ± 0.56 3.34 ± 0.67
Post 3.13 ± 0.56 2.35 ± 0.67
Antioxidant capacity (mM)
Pre 0.79 ± 0.05b 0.83 ± 0.05b
Post 0.96 ± 0.06a 1.10 ± 0.06a
Malondialdehyde (μM)
Pre 29 ± 7b 56 ± 8a
Post 13 ± 7c 22 ± 8bc
a,cMeans with unlike superscript are significantly (P ≤ 0.05) different from each
other.
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triglycerides, and LDL cholesterol were not affected by
increased C-reactive protein and insulin in obese
women when compared to normal weight controls sug-
gesting that the increase in inflammatory markers have
no effect on lipid panel status [46]. Therefore, we con-
clude that the high mean cholesterol and triglyceride
concentrations are attributed to the diet and the eating
habits rather than to inflammatory stimulation.
It is interesting to note that the increase in the plasma
antioxidant status and the decrease in the plasma mal-
ondialdehyde may have been related to drinking carrot
juice which is a good source of b-carotenes and a-caro-
tenes with antioxidant activity. In a similar study, drink-
ing kale juice significantly improved antioxidant status
without affecting the concentration of malondialdehyde
[47]. The inconsistency in results is probably due to the
amount of juice consumed. In the current study, the
participants consumed 16 fl oz (480 mL) of fresh carrot
juice everyday while in the study reported by Kim and
colleagues, the participants drank 5 ounces (150 mL) of
Kale juice daily [47].
Our results support the notion that physiological dif-
ferences exist between the male and female subjects.
One of the physiological differences between the partici-
pants are sex hormones causing men to weigh more and
have a lower body fat percentage then the female coun-
terpart [48,49]. Furthermore, the higher plasma leptin
and insulin concentrations in females agrees with earlier
reports and the differences could also be attributed to
sex hormones as observed in one other study [50]. How-
ever, the elevated plasma interleukin-1a, Apo B, and
malondialdehyde in men suggest that men are at a
greater risk for developing CVD than women. Moreover,
decreased lipid peroxidation evident from drinking car-
rot juice is associated with increased antioxidant status
independent of inflammatory markers, hormones, or
increased cholesterol and triglyceride concentrations.
Conclusion
In conclusion, drinking 16 fl oz of fresh carrot juice
daily significantly increased antioxidant status and sup-
pressed lipid peroxidation without affecting the plasma
cholesterol and triglyceride status. It appears both diet-
ary and lifestyle change are required to positively alter
lipid profiles in place of increasing fruits or vegetable
serving sizes without comprehensive dietary modifica-
tions. However, future studies are needed to either
refute or validate the results and conclusion of this
study.
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